Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit

Video   Jul 07, 2015

 

Molecular imaging is increasingly being used to support decision-making in early-stage drug development, particularly in the CNS. Providing invaluable information on the so-called ‘three pillars of drug survival’, namely tissue delivery, target engagement and pharmacological effect, it can be seen as a kind of precision pharmacology However, a lack of appreciation of when and how to use imaging and a lack of suitable tools means imaging is often an afterthought and employed in a post-mortem of drug failure. Timely development of imaging biomarkers will ensure the full translational value of this technology can be realised 

 
 
 
 

Recommended Videos

Behind the Science, S2 Ep8: Dimple Shah on how to tell if rice is organic

Video

Jen talks with Dimple Shah about how analytical science is used and the sensitivity of LC-MS/MS required to detect pesticide residues in rice, and unexpected detection of residues in an organic rice sample.

WATCH NOW

Scientist Feedback on the NanoDrop One Microvolume UV-Vis Spectrophotometer

Video

Watch this testimonial video with a University of Cambridge scientist who studies the chemical biology of nucleic acids.

WATCH NOW

The All New Affinity ITC - Perfected ITC Automation

Video

While others have attempted ITC automation, leading to bent syringes and imperfect data, TA Instruments has perfected it with the all new Affinity ITC!

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE